Browsing "Comunicações em Eventos - LIM/24" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 451 to 470 of 577 < previous   next >
Issue DateTitleAuthor(s)
2017Quality of life and economic outcomes of on-pump and off-pump stable multivessel coronary artery bypass grafting - MASS III trial 5-year follow-upSCUDELER, T. L.; HUEB, W.; SOAREZ, P. C. De; CAMPOLINA, A. G.; REZENDE, P. C.; LIMA, E. G.; GARZILLO, C. L.; AZEVEDO, D. F. C.; COSTA, L. M. A.; OIKAWA, F. T. C., et al
2017Quality of Life in Responders after Palliative Radiation Therapy for Painful Bone MetastasesMENDEZ, L. C.; PADILHA, J. L.; LIMA, K. M.; CHOW, E.; MORAES, F. Y.; ESTEVES, M. D. P. E.; SILVA, M. F.; MARTA, G. N.
2020Radiation Pneumonitis in Patients with Interstitial Lung Disease and Lung Cancer: Report of 6 CasesFREITAS, L. V. de; SERRA, J. P.; NAJAS, G. F.; PRADO, G. F.; KAWASSAKI, A. M.; TAKAGAKI, T. Y.; GABRIELLI, F.; JUNIOR, G. C.; OLIVEIRA, M. R.; KAIRALLA, R. A., et al
2021Radioactive and near-infrared fluorescence in vivo imaging of Non-Hodgkin Lymphoma using 99mTc/Cy7-Fab(Bevacizumab)CAMACHO, X.; PERRONI, C.; CARNEIRO, C.; JUNQUEIRA, M.; FARIA, D.; GARCIA, M.; FERNANDEZ, M.; BUCHPIGUEL, C.; CERECETTO, H.; CHAMMAS, R., et al
2018Randomised phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with OV versus gemcitabine (GEM) and P followed by maintenance with GEM as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological typeGROSSI, F.; JASKIEWICZ, P.; PICHON, E.; CZYZEWICZ, G.; KOWALSKI, D. M.; CIUFFREDA, L.; GOMEZ, R. Garcia; CARUSO, S.; BARRERA, J. Bosch; MINH, C. Ta Thanh, et al
2021Randomized controlled trial comparing holmium laser en-bloc resection with monopolar transurethral resection in patients with large bladder tumorsISCAIFE, A.; RIBEIRO FILHO, L. A.; PEREIRA, M. W. Aparecido; GALLUCCI, F. Pescarmona; CHADE, D.; CARDILI, L.; COELHO, R. F.; SARKIS, A. Sadeki; SROUGI, M.; NAHAS, W. C.
2022RANDOMIZED CONTROLLED TRIAL COMPARING UNDERWATER AND CONVENTIONAL ENDOSCOPIC MUCOSAL RESECTION FOR NON-PEDUNCULATED COLORECTAL LESIONSLENZ, Luciano H.; MARTINS, Bruno; PAULO, Gustavo A. De; KAWAGUTI, Fabio S.; BABA, Elisa R.; UEMURA, Ricardo S.; GUSMON, Carla C.; GEIGER, Sebastian N.; MOURA, Renata N.; PENNACCHI, Caterina, et al
2022Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic response and PSMA imaging correlates.BASTOS, Diogo Assed; COELHO, Rafael; CARDILI, Leonardo; GALIZA, Felipe; ILARIO, Eder Nisi; VIANA, Ublio; MURTA, Claudio Bovolenta; GUGLIELMETTI, Giuliano; CORDEIRO, Mauricio; PONTES JR., Jose, et al
2018Randomized phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with single-agent OV versus (vs) gemcitabine (GEM) and P followed by maintenance with single-agent GEM as first-line chemotherapy (CT) in locally advanced (LA) or metastatic non-small-cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type.GROSSI, Francesco; JASKIEWICZ, Piotr; PICHON, Eric; CZYZEWICZ, Grzegorz; KOWALSKI, Dariusz; CIUFFREDA, Libero; GARCIA-GOMEZ, Ramon; CARUSO, Salvatore; BOSCH-BARRERA, Joaquim; MINH, Christine Ta Thanh, et al
2012A randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: The LARCID trial.HOFF, Paulo Marcelo; SARAGIOTTO, Daniel Fernandes; BARRIOS, Carlos H.; GIGLIO, Auro Del; COUTINHO, Anelisa Kruschewsky; ANDRADE, Aline C.; DUTRA, Carolina; FORONES, Nora; CORREA, Mariangela; PORTELLA, Maria Socorro, et al
2013RANDOMIZED PHASE-3 TRIAL (INSPIRE) OF NECITUMUMAB PLUS CISPLATIN-PEMETREXED VERSUS CISPLATIN-PEMETREXED ALONE AS FIRST-LINE THERAPY IN STAGE IV NON-SQUAMOUS NSCLCPAZ-ARES, Luis; MEZGER, Jorg; CIULEANU, Tudor; FISCHER, Jurgen R.; PAWEL, Joachim Von; PROVENCIO, Mariano; KAZARNOWICZ, Andrzej; LOSONCZY, Gyoergy; CASTRO JR., Gilberto; SZCZESNA, Aleksandra, et al
2020A randomized, open-label, parallel-design phase III study to compare adjuvant 5-FU plus oxaliplatin (mFLOX) versus observation in locally advanced rectal cancer after neoadjuvant chemoradiationBRAGHIROLI, M. I.; MONIZ, C. M. V.; RIECHELMANN, R. S. P.; DORNELLAS, A. F. L.; CAPARELLI, F.; ALBAN, L.; ALEX, A.; BARIANI, G. M.; LEITE, L. A. Senna; RIVELLI, T. Giollo, et al
2022Rare intrascrotal tumors in a tertiary cancer center: A retrospective case series.CUNHA, Mateus Trinconi; CARDOSO, Camila; FREITAS, Guilherme Fialho de; SILVA, Jamile Almeida; MUNIZ, David Queiroz Borges; BASTOS, Diogo Assed; CARDILI, Leonardo; MOTA, Jose Mauricio
2017Real World data and patterns of care of metastatic breast cancer (MBC) in Brazil: First results of LACOG 0312 retrospective studyBARRIOS, C. H.; UEMA, D.; CRONENBERGER, E.; LIMA, V.; BINES, J.; SANT'ANA, R. O. de; BATISTA, M. L.; DYBAL, V.; LIEDKE, P.; BEATO, C., et al
2019Real world data on adjuvant chemotherapy for high-risk stage II colorectal cancer: The role of tumour sideCARVALHO, C. S. Araujo de; MONIZ, C. M. V.; WATARAI, G. Y.; CRESPO, J. A. R.; NOGUEIRA, P. V. D. S.; MARTINEZ, J. K.; MORAES, P. M. G. D.; BONADIO, R. R. D. C. C.; BRAGHIROLI, M. I. F. M.; SABBAGA, J., et al
2019REAL-LIFE EXPERIENCE OF TRASTUZUMAB USE AMONG 806 BREAST CANCER PATIENTS: ROLE OF ROUTINE SERIAL ECHOCARDIOGRAPHY FOR THE EVALUATION OF ASYMPTOMATIC VENTRICULAR DYSFUNCTION IN THE FIRST 6 MONTHS OF TRASTUZUMAB THERAPYSILVA, Carolina M. P. D. Carvalho; BITTENCOURT, Marcio; SANTOS, Marilia; BITTAR, Cristina; FONSECA, Silvia; PINTO, Giovanni; COSTA, Isabela; FIGUEIREDO, Clara; SIQUEIRA, Julio; BOND, Marina, et al
2023Real-world clinical characteristics and treatment (tx) outcomes by co-mutation status in patients (pts) with <i>KRAS G12C</i>- mutated non-small cell lung cancer (NSCLC)NEGRAO, Marcelo V.; WU, Wen-Hsing; LINDSAY, Colin R.; CAPARICA, Rafael; PRETRE, Vincent; KANG, Yehrim; CARO, Nydia; FARAGO, Anna; YE, Fen; CASTRO JR., Gilberto de
2020Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI)KHAKI, Ali Raza; DIAMANTOPOULOS, Leonidas Nikolaos; MILLER, Natalie J.; BILEN, Mehmet Asim; SANTOS, Victor Sacristan; MORALES-BARRERA, Rafael; DEVITT, Michael Edward; NELSON, Ariel Ann; SHRECK, Evan; ASSI, Hussein, et al
2013Recall rate in a semi-annual breast surveillance program for high-risk women.ABE, Hiroyuki; GUINDALINI, Rodrigo Santa Cruz; OBEID, Elias; PATRICK-MILLER, Linda J.; BRADBURY, Angela R.; VERP, Marion S.; HONG, Susan; WROBLEWSKI, Kristen; KARCZMAR, Greg S.; NEWSTEAD, Gillian, et al
2020Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program.MCCLEARY, Nadine Jackson; HARMSEN, William S.; VANCUTSEM, Eric; SOBRERO, Alberto F.; GOLDBERG, Richard M.; TABERNERO, Josep; SEYMOUR, Matt; SALTZ, Leonard B.; GIANTONIO, Bruce J.; DIRK, Arnold, et al